China Justice Observer

中司观察

EnglishArabicChinese (Simplified)DutchFrenchGermanHindiItalianJapaneseKoreanPortugueseRussianSpanishSwedishHebrewIndonesianVietnameseThaiTurkishMalay

Shenzhen Issues China’s First Local Regulation on Cell and Gene Industry

Mon, 24 Jul 2023
Categories: China Legal Trends

The legislation refers to the “Regulation on the Promotion of Cell and Gene Industry in the Shenzhen Special Economic Zone” (hereinafter the “Regulation”, 深圳经济特区细胞和基因产业促进条例), which was adopted by the Standing Committee of the Shenzhen People’s Congress on 6 Jan. 2023.

The highlights of the Regulation are as follows.

  • The Regulation applies to the research and development, production, operation, application and guarantee of cell and gene products for disease diagnosis and treatment in the Shenzhen Special Economic Zone.
  • Before collecting cells, enterprises, scientific research institutions, medical and health institutions and entrusted institutions shall clearly inform the subject of the collection purpose, collection use, possible impact on health, personal privacy protection measures, rights and obligations of the subject, and obtain the written consent of the subject.
  • Enterprises, universities, scientific research institutions, and medical institutions are supported to cooperate in clinical research and trials in the field of cells and genes.
  • For cell and gene drugs undergoing clinical trials to treat severe life-threatening diseases for which there is no effective treatment after medical analysis finds that the benefits may outweigh the risks and meet ethical requirements, they shall be reviewed per national regulations and obtain informed consent. After that, the drugs shall be used in other patients with the same condition and unable to participate in drug clinical trials through extended trials within the medical institutions conducting clinical trials.
  • Enterprises and scientific research institutions are supported to carry out research on gene sequencing technology and biological information analysis technology and develop gene sequencing tools with core intellectual property rights, as well as supporting equipment, software and databases.

 

 

Photo by Bosi Zhang on Unsplash

Contributors: CJO Staff Contributors Team

Save as PDF

You might also like

China Eases Tax Refunds to Boost Inbound Tourist Spending

In 2025, China has lowered its departure tax refund threshold from 500 RMB to 200 RMB and doubled cash refund limits to 20,000 RMB while expanding eligible stores and streamlining processes, aiming to boost inbound tourism spending and promote Chinese products.

Chinese Courts Bolster Pregnant Workers' Rights Protection

In April 2025, China's Ministry of Human Resources and Supreme People's Court released typical labor dispute cases emphasizing stronger protection of pregnant employees' rights, including a case where unlawful job reassignment and salary reduction were ruled illegal.

China Revises Marriage Registration Regulation

China's revised marriage registration rules, effective May 2025, eliminate location restrictions, simplify procedures by removing hukou requirements, and align divorce processes with the Civil Code's cooling-off period.

China’s SPC Issues Foreign State Immunity Case Guidelines

In March 2025, China's Supreme People's Court (SPC) issued procedural guidelines for handling civil cases involving foreign state immunity, implementing the country's shift from absolute to restrictive immunity under the new Foreign State Immunity Law.

SPC Issues Prepaid Consumption Rules & Typical Cases

In March 2025, China’s Supreme People’s Court (SPC) issued a judicial interpretation and six guiding cases to tackle prepaid consumption disputes, invalidating unfair terms, protecting consumer refunds, and penalizing merchants who abscond with prepayments.

SPP Releases Guiding Cases on Civil Adjudication Supervision

In March 2025, China’s Supreme People’s Procuratorate (SPP) released new guiding cases to strengthen supervision over civil judgments, ensuring fairness and correcting errors in court rulings, covering disputes like private loans and traffic accidents.

First Tort Suit Under China’s Anti-Foreign Sanctions Law

In March 2025, China’s Supreme People’s Court (SPC) reported the first-ever tort suit under the Anti-Foreign Sanctions Law, enabling a Chinese firm to recover over CNY 84 million after a European partner withheld payment invoking a third country’s sanctions.